Literature DB >> 19422605

Topical vitamin D analogues in the treatment of vitiligo.

Davinder Parsad, A J Kanwar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19422605     DOI： 10.1111/j.1755-148X.2009.00579.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  4 in total

1.  CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.

Authors:  Jonathan M Eby; Hee-Kap Kang; Sean T Tully; Wendy E Bindeman; Daniel S Peiffer; Shilpak Chatterjee; Shikhar Mehrotra; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2015-01-09       Impact factor: 8.551

2.  Cancer Risks in Vitiligo Patients: A Nationwide Population-Based Study in Taiwan.

Authors:  Cheng-Yuan Li; Ying-Xiu Dai; Yi-Ju Chen; Szu-Ying Chu; Tzeng-Ji Chen; Chen-Yi Wu; Chih-Chiang Chen; Ding-Dar Lee; Yun-Ting Chang
Journal:  Int J Environ Res Public Health       Date:  2018-08-27       Impact factor: 3.390

Review 3.  Vitamin D and the skin: Focus on a complex relationship: A review.

Authors:  Wedad Z Mostafa; Rehab A Hegazy
Journal:  J Adv Res       Date:  2014-02-08       Impact factor: 10.479

4.  Impact of vitamin D receptor gene polymorphisms on vitiligo susceptibility and clinical features in a Southeastern European Caucasian population.

Authors:  Martha-Spyridoula Katsarou; Polytimi Sidiropoulou; Dimitra Ieronymaki; Styliani Mastraftsi; Maria Sifaki; Kyriakos Xenos; Alexander Nosyrev; Leda Kovatsi; Demetrios A Spandidos; Maria Lagiou; Christos Dagklis; Stamatis Gregoriou; Anna Tagka; Dimitris Rigopoulos; Nikolaos Drakoulis; Electra Nicolaidou
Journal:  Int J Mol Med       Date:  2020-09-18       Impact factor: 4.101
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.